发明名称 |
NOVEL TRANSLOCATIONS IN LUNG CANCER |
摘要 |
The invention relates to methods for determining the presence or absence of striatin-anaplastic lymphoma kinase (STRN-ALK) gene fusion and/or a Fibroblast Growth Factor Receptor 3—transforming acidic coiled-coil containing protein 3 (FGFR3-TACC3) gene fusion in an individual, especially an individual suffering from lung cancer. The invention further relates to a method for diagnosing an individual as having adenocarcinoma, and to a method for treating said individual. The invention additionally relates to a method for diagnosing an individual as having squamous cell carcinoma, and to a method for treating said individual. |
申请公布号 |
US2016186269(A1) |
申请公布日期 |
2016.06.30 |
申请号 |
US201414893991 |
申请日期 |
2014.05.27 |
申请人 |
STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS ;AGENDIA N.V. |
发明人 |
Bernards Rene;Majewski Ian Jordan;Mittempergher Lorenza |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for determining the presence or absence of striatin-anaplastic lymphoma kinase (STRN-ALK) gene fusion and/or a Fibroblast Growth Factor Receptor 3—transforming acidic coiled-coil containing protein 3 (FGFR3-TACC3) gene fusion in an individual, said method comprising:
a) evaluating a relevant nucleic acid sample of said individual to determine whether a portion of STRN nucleic acid is adjacent to a portion of ALK nucleic acid on a single polynucleotide and/or whether a portion of FGFR3 nucleic acid is adjacent to a portion of TACC3 nucleic acid on a single polynucleotide; and b) identifying said individual as having a STRN-ALK gene fusion when a portion of the STRN nucleic acid is adjacent to a portion of the ALK nucleic acid on a single polynucleotide and/or as having a FGFR3-TACC3 gene fusion when a portion of the FGFR3 nucleic acid is adjacent to a portion of the TACC3 nucleic acid on a single polynucleotide. |
地址 |
Amsterdam NL |